(Q37710669)

22 August 2017

1 reference

title

mTOR inhibitor-associated dermatologic and mucosal problems (English)

1 reference

22 August 2017

6

Eggert Stockfleth

1 reference

22 August 2017

Josep M Campistol

1

1 reference

22 August 2017

Johan W de Fijter

2

1 reference

22 August 2017

Stuart M Flechner

3

1 reference

22 August 2017

Anthony Langone

4

1 reference

22 August 2017

Emmanuel Morelon

5

1 reference

22 August 2017

publication date

4 March 2010

1 reference

22 August 2017

published in

Clinical Transplantation

1 reference

22 August 2017

volume

24

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

149-156

1 reference

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Center experience in liver transplantation (LTX): management of dermal side effects caused by sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Skin reactions related to treatment with anticytokines, membrane receptor inhibitors and monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Involvement of the Akt/mTOR pathway on EGF-induced cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

[Skin diseases in organ transplant patients]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Clinical practice. Aphthous ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

A comparative study of sirolimus tablet versus oral solution for prophylaxis of acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Sirolimus-induced leukocytoclastic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Sirolimus-induced leukocytoclastic vasculitis: the second case reported

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Gastrointestinal leukocytoclastic vasculitis: an adverse effect of sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Colonic perforation associated with leukocytoclastic vasculitis caused by Sirolimus toxicity following renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Cutaneous vasculitis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

A palpable clue to vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Cutaneous and systemic manifestations of drug-induced vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Sirolimus-associated chronic pyogenic periungual infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Population pharmacokinetics of CCI-779: correlations to safety and pharmacogenomic responses in patients with advanced renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01232.X

10.1111/J.1399-0012.2010.01232.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference